The SARS-CoV-2 Detection Kit is developed for qualitative detection of SARS-CoV-2 that is collected from human nasopharyngeal swabs, sputum and bronchoalveolar lavage fluid in vitro. It is only used as an in vitro diagnostic emergency response for SARS-CoV-2 infection happened in December 2019. It is suggested to follow the newest document instructions of “Diagnosis and treatment of novel coronavirus infection pneumonia” and “Strategic Preparation and Response Plan of novel coronavirus infection pneumonia” (current version). The novel coronavirus detection should meet the requirements of "new laboratory technology related to new coronavirus pneumonia detection guidelines" and address biosafety issues.